Cargando…
The role of methylenetetrahydrofolate reductase C677T gene polymorphism as a risk factor for coronary artery disease: a cross-sectional study in the Sidoarjo Regional General Hospital
INTRODUCTION: hyperhomocysteinemia (HHcy) may contribute to an increased risk of coronary artery disease (CAD). The underlying mechanisms are not well understood, but other than dietary intake factors, hyperhomocysteinemia may genetically result from a methylenetetrahydrofolate reductase (MTHFR) C67...
Autores principales: | Sugijo, Hairudi, Sargowo, Djanggan, Widjajanto, Edi, Romdoni, Rochmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167480/ https://www.ncbi.nlm.nih.gov/pubmed/35721657 http://dx.doi.org/10.11604/pamj.2022.41.212.24916 |
Ejemplares similares
-
Thermolabile Methylenetetrahydrofolate Reductase C677T Polymorphism and Homocysteine Are Risk Factors for Coronary Artery Disease in Moroccan Population
por: Bennouar, Nawal, et al.
Publicado: (2007) -
Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in eastern Uttar Pradesh
por: Rai, Vandana, et al.
Publicado: (2012) -
Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in
psoriasis in southern Turkey
por: Izmirli, Muzeyyen, et al.
Publicado: (2016) -
Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes
por: Pollex, Rebecca L, et al.
Publicado: (2005) -
Relationship of the 1793G-A and 677C-T Polymorphisms of the 5,10-Methylenetetrahydrofolate Reductase Gene to Coronary Artery Disease
por: Kebert, Cory B., et al.
Publicado: (2006)